Investigators compared 3 machine learning models against the often used HAS-BLED risk score in predicting GIB in patients using antithrombotic drugs.
Investigators assessed the effectiveness of Hemospray for the management of GI bleeding.
Researchers compared the performance of multiple risk stratification scores used in the assessment of patient outcomes with upper GI bleeding.
Researchers aimed to assess the impact of aspirin on incidence of serious GI bleeding in an older population, identify risk factors, and calculate absolute bleeding risk according to age and presence of risk factors.
EndoClot PHS is a single-use device consisting of a starch-based powder hemostat to control bleeding in the GI tract.
Investigators assessed the outcomes of patients with peptic ulcer and non-ulcer lesions who did or did not receive pre-endoscopic proton pump inhibitor therapy.
Danish investigators conducted a cohort study to assess the impact of low-dose aspirin on lower gastrointestinal bleeding, colorectal bleeding, and colorectal polyps.
Time to rebleeding was a significant predictor of mortality risk following an endoscopic variceal ligation procedure.
Ticagrelor and prasugrel, the newer generation of P2Y12-inhibiting antiplatelet agents, were found to be associated with fewer gastrointestinal bleeding events the first year after percutaneous coronary intervention compared with clopidogrel.
Researchers conducted a meta-analysis to evaluate prophylactic clipping in preventing post-polypectomy bleeding and published the results in Gastroenterology.
The COVID-19 pandemic has caused physicians in the New York area to reevaluate how they care for patients with gastrointestinal (GI) diseases.
Patients with acute lower gastrointestinal bleeding (LGIB) had similar clinical outcomes regardless of admission day.
A scoring system to aid in the simple triage of patients with upper gastrointestinal bleeding (UGIB) outperformed existing clinical scoring systems.
The absolute 1-year risk of colorectal cancer in patients with atrial fibrillation treated with oral anticoagulants is not trivial.
Investigators examined how systemic sclerosis may predict long-term risk for gastrointestinal bleeding, including the bleeding of upper and lower gastrointestinal tracts.
In patients with acute lower gastrointestinal bleeding (ALGIB), colonoscopies performed within 24 hours after hospital admission did not reduce rebleeding or increase stigmata of recent hemorrhage (SRH) compared with colonoscopies performed between 24 to 96 hours after hospital admission.
Patients who restart their blood thinners after a gastrointestinal bleed have a lower risk for dying within the next two years even though they have a higher risk for recurrent gastrointestinal bleeding.
Patients with bleeding gastrointestinal angiodysplasias who are receiving antithrombotic therapy have a lower probability of rebleeding when treated with hemoclips (in combination or as monotherapy), compared with the use of argon plasma photocoagulation.
The incidence of gastrointestinal bleeding was noted in patients taking angiotensin II receptor blockers, and no association was found between proton pump inhibitors and gastrointestinal bleeding.
Resumption of warfarin post-hospitalization for gastrointestinal bleeding (GIB) was associated with an increased risk for recurrent GIB compared with direct oral anticoagulants.